Snapshots of the dynamic basis of NTSR1 G protein subtype promiscuity
Summary
This Nature paper uses time-resolved cryo-EM, single-molecule fluorescence, molecular dynamics and kinetic BRET to capture multiple intermediate states in the GTP-driven activation cycle of the neurotensin receptor 1 (NTSR1) when bound to two different G protein families: Gi1 and G11. The authors resolve canonical (C) and non-canonical (NC) receptor–G protein orientations and show that these orientations can bind GTP and populate distinct closed and open states of the G protein alpha-helical domain (AHD). Crucially, NTSR1–G11 releases GTP-bound G protein far faster and shows fewer stable intermediates than NTSR1–Gi1, implicating differences in intracellular loops (ICL2/ICL3), TM5–TM6, and G protein sequence elements (α5, β2–β3) as drivers of subtype selectivity and signalling efficiency.
Key Points
- Time-resolved cryo-EM captured four shared intermediate states for NTSR1–Gi1 during GTP-induced activation: C-open, NC-open, C-closed and NC-closed (AHD open/closed distinctions resolved at 2.1–3.0 Å).
- The NC orientation is not a dead-end: NC complexes can bind GTP and are likely both an intermediate on the way to activation and a state during dissociation.
- NTSR1–G11 shows C and NC nucleotide-free states, but after GTP addition the complexes rapidly move to C-closed-like states and then dissociate, with far fewer resolvable intermediates than Gi1.
- Single-molecule fluorescence shows GTP-induced dissociation times ≈15 s for G11 versus ≈37 s for Gi1 — ~2.5-fold faster release for G11.
- ICL2 and the TM5–ICL3–TM6 region of the receptor, together with G protein regions (α5 hook, β2–β3 loop, linker I), shape the stability and population of intermediates and so influence subtype selectivity.
- ICL2 swaps between NTSR1 and μ-opioid receptor (MOR) alter signalling amplitude and kinetics, confirming that intracellular loop sequences tune intermediate formation and downstream signalling.
- Molecular dynamics and 3D variability analysis support that small sequence differences alter α1/α5/β2–β3 behaviour and the propensity for AHD closure or α5 disengagement — key determinants of activation kinetics.
- Equilibrium, nucleotide-free structures alone are insufficient to predict coupling selectivity; the full association–nucleotide exchange–dissociation pathway and lifetimes of intermediates matter for functional selectivity and drug design.
Content summary
The authors purified wild-type NTSR1 complexes with Gi1 and G11, produced grids at 6 s and 20 s after adding GTP and reconstructed multiple intermediate states by cryo-EM. For Gi1 they resolved both C and NC orientations in apo and GTP-bound forms, and two AHD-closed GTP-bound intermediates where intracellular loops drive most receptor–G contacts. For G11, although C and NC apo states exist, addition of GTP rapidly produced primarily C-closed-like states and then dissociation; NC-closed GTP-like intermediates were essentially absent.
Biophysical assays (single-molecule fluorescence, kinetic BRET) and MD simulations corroborated structural findings: G11 dissociates more quickly, and swapping ICLs between receptors shifts kinetics and efficacy. Sequence comparisons highlight conserved versus family-specific residues in both receptors and G proteins that modulate intermediate stability.
Context and relevance
This work addresses a major question in GPCR biology: how receptors that can engage multiple G protein subtypes bias signalling. Instead of a single static binding mode determining selectivity, the paper shows that dynamic intermediate states and their lifetimes — shaped by intracellular loops and specific G protein motifs — determine which G protein is activated efficiently. That reframes efforts to design biased ligands or intracellular modulators: you need to consider how molecules change the energy landscape and intermediates, not just the nucleotide-free end-state.
Why should I read this?
Short: if you care about how GPCRs pick their G proteins or want to design biased drugs, this paper is gold. It actually watches the activation pathway unfold, shows that different G proteins take different routes (and speeds), and points to the exact receptor and G protein bits that control that behaviour. Saves you reading a stack of background papers — they’ve done the heavy lifting and give clear places to target for experiments or drug design.
Author style
Punchy: the authors combine cutting-edge time-resolved cryo-EM with single-molecule and functional assays to make a tight, high-confidence case that dynamics and intermediates — not just static fits — underlie G protein subtype promiscuity. This is highly relevant for anyone working on GPCR signalling, biased agonism, or structure-guided ligand design.